Office for the Advancement of Developing Industries: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
The '''Office for the Advancement of Developing Industries''' ('''OADI''') is an business incubator operated by [[UAB]] with a focus on medical and biotechnological research and development. It was founded in [[1997]] | The '''Office for the Advancement of Developing Industries''' ('''OADI''') is an business incubator operated by [[UAB]] with a focus on medical and biotechnological research and development. It was founded in [[1983]] as the '''Center for the Advancement of Developing Industries]] with [[James Woodward]] as director. | ||
In [[1997]] the center was renamed and moved to a 68,500 square-foot building in the [[UAB Research Park]] in [[Oxmoor]]. | |||
In [[2007]] OADI relocated to the [[Innovation Depot]] in downtown [[Birmingham]] along with the [[Entrepreneurial Center]]. The 1997 building has been put on the market with an asking price of $10 million. It was thought to have been a leading contender for a new influenza vaccine manufacturing plant planned by Solvay Pharmaceuticals. Solvay decided not to build a plant, however. | In [[2007]] OADI relocated to the [[Innovation Depot]] in downtown [[Birmingham]] along with the [[Entrepreneurial Center]]. The 1997 building has been put on the market with an asking price of $10 million. It was thought to have been a leading contender for a new influenza vaccine manufacturing plant planned by Solvay Pharmaceuticals. Solvay decided not to build a plant, however. | ||
Revision as of 20:02, 27 June 2009
The Office for the Advancement of Developing Industries (OADI) is an business incubator operated by UAB with a focus on medical and biotechnological research and development. It was founded in 1983 as the Center for the Advancement of Developing Industries]] with James Woodward as director.
In 1997 the center was renamed and moved to a 68,500 square-foot building in the UAB Research Park in Oxmoor.
In 2007 OADI relocated to the Innovation Depot in downtown Birmingham along with the Entrepreneurial Center. The 1997 building has been put on the market with an asking price of $10 million. It was thought to have been a leading contender for a new influenza vaccine manufacturing plant planned by Solvay Pharmaceuticals. Solvay decided not to build a plant, however.
References
- Kent, Dawn (March 1, 2007) "Southpace hired to sell building." Birmingham News.
External links
- OADI website